The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 05, 2017
Filed:
May. 31, 2016
Applicant:
Biovascular, Inc., San Diego, CA (US);
Inventors:
Paul F. Glidden, San Diego, CA (US);
Alison J. Pilgrim, Castillon-du-Gard, FR;
Stephen R. Hanson, Edmonds, WA (US);
Assignee:
BioVascular, Inc., San Diego, CA (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/00 (2006.01); A61K 31/519 (2006.01); A61K 9/48 (2006.01);
U.S. Cl.
CPC ...
A61K 9/1676 (2013.01); A61K 9/0053 (2013.01); A61K 9/1617 (2013.01); A61K 9/1652 (2013.01); A61K 9/2013 (2013.01); A61K 9/2054 (2013.01); A61K 9/2081 (2013.01); A61K 9/4808 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 31/519 (2013.01);
Abstract
Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.